Partner at Apollo Health Ventures since September 2021, with over 10 years of experience in the life science industry spanning venture investing, strategy consulting and research.

Prior to joining the Apollo team, Marianne was a Principal with Wellington Partners, a pan-European Venture Capital firm investing in early- and growth-stage Life Science companies. Marianne also worked as an Investment Manager at High-Tech Gründerfonds, where she managed a portfolio of seven companies and concluded the initial investments in Cardior Pharmaceuticals and Verovaccines.

Marianne obtained a Bachelor’s and Master’s degree with distinction in Biotechnology from the RWTH Aachen University and The Scripps Research Institute, and conducted her PhD research focusing on the molecular imaging of cardiac regenerative medicines.